Cellect Biotechnology Ltd.

( )
APOP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -6.69%53.850.0%$1434.61m
GILDGilead Sciences, Inc. -0.44%72.861.0%$1281.80m
AMGNAmgen, Inc. 0.05%222.501.3%$637.75m
REGNRegeneron Pharmaceuticals, Inc. -1.63%536.302.5%$606.91m
NVAXNovavax, Inc. -1.06%47.66102.0%$602.22m
VRTXVertex Pharmaceuticals, Inc. 0.15%266.901.9%$517.10m
BIIBBiogen, Inc. 0.82%298.291.6%$416.40m
ILMNIllumina, Inc. -0.08%354.413.5%$354.75m
SRNESorrento Therapeutics, Inc. 2.47%5.401.8%$314.63m
SGENSeattle Genetics, Inc. 1.50%154.006.1%$246.68m
ALXNAlexion Pharmaceuticals, Inc. 1.17%104.002.0%$226.68m
AAgilent Technologies, Inc. 1.37%86.141.6%$196.15m
CODXCo-Diagnostics, Inc. -0.44%17.950.0%$185.10m
MGNXMacroGenics, Inc. -6.82%23.646.2%$178.27m
BMRNBioMarin Pharmaceutical, Inc. 6.39%103.744.3%$172.63m

Company Profile

Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel.